IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+35.4%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$328M
AUM Growth
+$328M
(+46%)
Cap. Flow
+$56M
Cap. Flow
% of AUM
17.07%
Top 10 Holdings %
Top 10 Hldgs %
34.61%
Holding
78
New
27
Increased
13
Reduced
13
Closed
18
Top Buys
| 1 |
LHCG
LHC Group LLC
LHCG
|
$13.1M |
| 2 |
Charles River Laboratories
CRL
|
$9.59M |
| 3 |
Cencora
COR
|
$9.07M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.65M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$7.48M |
Top Sells
| 1 |
Medtronic
MDT
|
$10.4M |
| 2 |
Centene
CNC
|
$10.1M |
| 3 |
Encompass Health
EHC
|
$7.36M |
| 4 |
Masimo
MASI
|
$6.2M |
| 5 |
Novartis
NVS
|
$5.77M |
Sector Composition
| 1 | Healthcare | 88.41% |
| 2 | Energy | 6.64% |
| 3 | Technology | 0.85% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MacroGenics
MGNX
$112M
| $1.95M | 0.59% | +70,000 | New | +$1.95M |
|
|
ONC
52
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.88M | 0.56% | +10,000 | New | +$1.88M |
|
|
WBA
53
DELISTED
Walgreens Boots Alliance
WBA
| $1.7M | 0.51% | 40,000 -40,000 | -50% | -$1.7M |
|
54
PTC Therapeutics
PTCT
$3.92B
| $1.52M | 0.46% | +30,000 | New | +$1.52M |
|
|
GNMK
55
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.47M | 0.44% | +100,000 | New | +$1.47M |
|
56
Karyopharm Therapeutics
KPTI
$61.7M
| $1.42M | 0.43% | 75,000 -25,000 | -25% | -$474K |
|
57
Incyte
INCY
$16.5B
| $1.04M | 0.31% | +10,000 | New | +$1.04M |
|
|
BMY.RT
58
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $537K | 0.16% | 150,000 -300,000 | -67% | -$1.07M |
|
59
Akero Therapeutics
AKRO
$3.74B
| – | – | -60,000 | Closed | -$1.27M |
|
60
Alkermes
ALKS
$4.78B
| – | – | -150,000 | Closed | -$2.16M |
|
61
Arvinas
ARVN
$568M
| – | – | -40,000 | Closed | -$1.61M |
|
62
Becton Dickinson
BDX
$55.3B
| – | – | -25,000 | Closed | -$5.74M |
|
63
Boston Scientific
BSX
$156B
| – | – | -125,000 | Closed | -$4.08M |
|
64
Chewy
CHWY
$16.9B
| – | – | -100,000 | Closed | -$3.75M |
|
|
65
Centene
CNC
$14.3B
| – | – | -170,000 | Closed | -$10.1M |
|
|
66
Encompass Health
EHC
$12.3B
| – | – | -115,000 | Closed | -$7.36M |
|
67
Intuitive Surgical
ISRG
$170B
| – | – | -7,000 | Closed | -$3.47M |
|
|
68
Masimo
MASI
$7.59B
| – | – | -35,000 | Closed | -$6.2M |
|
|
69
Medtronic
MDT
$119B
| – | – | -115,000 | Closed | -$10.4M |
|
70
Moderna
MRNA
$9.37B
| – | – | 0 | – | – |
|
71
Minerva Neurosciences
NERV
$16.5M
| – | – | -250,000 | Closed | -$1.51M |
|
72
Novo Nordisk
NVO
$251B
| – | – | -55,000 | Closed | -$3.31M |
|
|
73
Novartis
NVS
$245B
| – | – | -70,000 | Closed | -$5.77M |
|
74
10x Genomics
TXG
$1.74B
| – | – | -40,000 | Closed | -$2.49M |
|
75
UnitedHealth
UNH
$281B
| – | – | -10,000 | Closed | -$2.49M |
|